Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b Conjugate, and Hepatitis B Vaccine, and Guidance for Use in Infants
  • Published Date:

    February 07 2020

  • Source:
    MMWR Morb Mortal Wkly Rep. 69(5):136-139
  • Language:
    English
Filetype[PDF-86.94 KB]


Details:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 1.60 MB]
    Published Date:
    October 3, 2008
    Source:
    MMWR. Morbidity and mortality weekly report. 2008; 57(39):1078-9.
    Description:
    On June 24, 2008, the Food and Drug Administration licensed a combined diphtheria and tetanus toxoids and acellular pertussis adsorbed (DTaP) and inactivated poliovirus (IPV) vaccine, DTaP-IPV (Kinrix, GlaxoSmithKline Biologicals, Rixensart, Belgium)...
    Status:
    superseded
    File Type:
    Filetype[PDF - 1.60 MB]
  2. Filetype[PDF - 1.60 MB]
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.. Centers for Disease Control and Prevention (U.S.).
    Published Date:
    October 3, 2008
    Source:
    MMWR. Morbidity and mortality weekly report. 2008; 57(39):1079-80.
    Description:
    On June 20, 2008 the Food and Drug Administration (FDA) licensed a combined diphtheria and tetanus toxoids and acellular pertussis adsorbed (DTaP), inactivated poliovirus vaccine (IPV), and Haemophilus influenzae type b conjugate (tetanus toxoid [TT]...
    Status:
    superseded
    File Type:
    Filetype[PDF - 1.60 MB]
  3. Filetype[PDF - 371.67 KB]
    Personal Author:
    Lee, Andrew W.
    Corporate Authors:
    Merck Research Laboratories.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2015 October 21 : Atlanta, GA)
    Published Date:
    October 21, 2015
    Series:
    ACIP meeting Combination Vaccines
    File Type:
    Filetype[PDF - 371.67 KB]
  4. Filetype[HTM]
    Published Date:
    September 18, 2009
    Source:
    MMWR. Morbidity and mortality weekly report. 2009; 58(36):1008-9.
    Description:
    On August 19, 2009, the Food and Drug Administration (FDA) licensed Hiberix (GlaxoSmithKline Biologicals, Rixensart, Belgium), a Haemophilus influenzae type b (Hib) conjugate vaccine composed of H. influenzae type b capsular polysaccharide (polyribos...
    Status:
    current
    File Type:
    Filetype[HTM]
  5. Filetype[PDF - 201.28 KB]
    Personal Author:
    Elam-Evans, Laurie D.; Yankey, David; Singleton, James A.; Sterrett, Natalie; Markowitz, Lauri E.; Williams, Charnetta L.; Fredua, Benjamin; McNamara, Lucy; Stokley, Shannon;
    Published Date:
    August 21 2020
    Source:
    MMWR Morb Mortal Wkly Rep. 69(33):1109-1116
    Description:
    Three vaccines are recommended by the Advisory Committee on Immunization Practices (ACIP) for routine vaccination of adolescents aged 11-12 years to protect against 1) pertussis; 2) meningococcal disease caused by types A, C, W, and Y; and 3) human p...
    File Type:
    Filetype[PDF - 201.28 KB]